Ebola vaccine to begin testing

p2270World-News-4-1

Published: Monday 13th October 2014 by The News Editor

Comments (0)

An experimental Canadian-made Ebola vaccine which has shown promise in tests on primates is beginning clinical trials on humans in the US.

The vaccine will be tested on healthy individuals to see how well it works, whether there are side effects and what the proper dosage is, Canada’s health minister Rona Ambrose said.

“The Canadian vaccine provides great hope and promise because it has shown to be 100% effective in preventing the spread of the Ebola virus when tested on animals,” she said.

Studies in primates have shown this vaccine works both to prevent infection when given before exposure, and to increase survival chances when given quickly after exposure.

US company NewLink Genetics holds the licence for the vaccine and the trials are set to begin in a lab in Maryland. Ms Ambrose said the results are expected in December.

NewLink said earlier this month that at least five clinical trials involving the vaccine, known as VSV-EBOV, would soon be under way in the United States, Germany, Switzerland and in an unnamed African country that is not battling Ebola.

Published: Monday 13th October 2014 by The News Editor

Comments (0)

Local business search